Background
Cardiovascular Imaging Technologies was the first company to release
a cardiac-specific misregistration correction software package in 2003.
Since that time, CVIT has developed correction routines for metial
artifacts in PET/CT imaging and a PET-specific interpretation
environment.
Radionuclide-based myocardial perfusion imaging utilizing positron
emission tomography (PET) is increasingly recognized as having
superior accurancy compared to single photon emission computed
tomography (SPECT)[1]. PET is not limited by many of the factors
affecting SPECT, and PET has proven in clinical studies to be superior
for thoese applications. Even when employed in a spatially-relative
manner, PET is more accurate for detecting the presence and extent of
CAD in both men and women[1]. Compared with SPECT, PET has an
almost two-fold improvement for correct detection of multivessel CAD.
PET has been shown to be especially useful in patients where SPECT
image quality is compromised by artifacts due to exaggerated body
habitus or scatter into the myocardium of tracer accumulated in
cardiac-adjacent structures.
The widespread availability of a generator-based radiotracer for
myocardial perfusion PET imaging as well as advanceds in PET
scanner technology has lead to an explosion in utilization. In 2000, only
8 sites in the United States were routinely performing myocaridal
perfusion imaging (MPI) PET; by the end of 2007 that number exceeded
100. This increase in utilization was driven by dramatic improvements
in image quality due in large part to the widespread availability of
cardiac-specific processing and interpretation software.
To achieve this level of accuracy in routine PET MPI, it is necessary to
acquire high quality data and process the data to remove imaging
artifacts. The most prevalent of these artifacts is misregistration
between transmission and emission data sets[2]. In addion, metal
artifacts correction in PET/CT[3] and regular use of PET specific QC
tools are essential for maintaining study accuracy
n the changing health care environment, staying on the cutting edge is
critical. With 10 years of experience and leadership in cardiac positron
emission tomography and SPECT imaging, Cardiovascular Imaging
Technologies (CVIT) has the products and services to meet the
demands of the most sophisticated nuclear cardiologists. Call us to
learn more about how PET can make a difference for your patients
(816-531-2842x107).
Cardiovascular Imaging Technologies was the first company to release
a cardiac-specific misregistration correction software package in 2003.
Since that time, CVIT has developed correction routines for metial
artifacts in PET/CT imaging and a PET-specific interpretation
environment.
Radionuclide-based myocardial perfusion imaging utilizing positron
emission tomography (PET) is increasingly recognized as having
superior accurancy compared to single photon emission computed
tomography (SPECT)[1]. PET is not limited by many of the factors
affecting SPECT, and PET has proven in clinical studies to be superior
for thoese applications. Even when employed in a spatially-relative
manner, PET is more accurate for detecting the presence and extent of
CAD in both men and women[1]. Compared with SPECT, PET has an
almost two-fold improvement for correct detection of multivessel CAD.
PET has been shown to be especially useful in patients where SPECT
image quality is compromised by artifacts due to exaggerated body
habitus or scatter into the myocardium of tracer accumulated in
cardiac-adjacent structures.
The widespread availability of a generator-based radiotracer for
myocardial perfusion PET imaging as well as advanceds in PET
scanner technology has lead to an explosion in utilization. In 2000, only
8 sites in the United States were routinely performing myocaridal
perfusion imaging (MPI) PET; by the end of 2007 that number exceeded
100. This increase in utilization was driven by dramatic improvements
in image quality due in large part to the widespread availability of
cardiac-specific processing and interpretation software.
To achieve this level of accuracy in routine PET MPI, it is necessary to
acquire high quality data and process the data to remove imaging
artifacts. The most prevalent of these artifacts is misregistration
between transmission and emission data sets[2]. In addion, metal
artifacts correction in PET/CT[3] and regular use of PET specific QC
tools are essential for maintaining study accuracy
n the changing health care environment, staying on the cutting edge is
critical. With 10 years of experience and leadership in cardiac positron
emission tomography and SPECT imaging, Cardiovascular Imaging
Technologies (CVIT) has the products and services to meet the
demands of the most sophisticated nuclear cardiologists. Call us to
learn more about how PET can make a difference for your patients
(816-531-2842x107).
Cardiovascular Imaging Technologies
 | |  | |  | |  | |  |
Imagen Family of
PET products
PET products
Visit CVIT at the
American Society of
Nuclear Cardiology
Annual Meeting at booth
#708
American Society of
Nuclear Cardiology
Annual Meeting at booth
#708
4320 Wornall Road, Suite 55
Kansas City, MO 64111
ph: 816-531-2842
fax: 816-531-0643
scourter@cvit.com
Kansas City, MO 64111
ph: 816-531-2842
fax: 816-531-0643
scourter@cvit.com
Copyright 2010 Cardiovascular Imaging Technologies. All rights reserved.